Barinthus Biotherapeutics (BRNS) Exchange Rate Effect (2020 - 2026)
Barinthus Biotherapeutics' (BRNS) quarterly Exchange Rate Effect came in at -$1.4 million in Q1 2026, down 143.84% YoY from $3.1 million in Q1 2025, and down 423.44% on a QoQ basis from $418000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 7 years of Exchange Rate Effect data on file, last reported at -$1.4 million in Q1 2026.
- Quarterly Exchange Rate Effect fell 143.84% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 65.72% YoY) and the FY2025 annual result came in at $7.0 million, up 447.01% from the prior year.
- Exchange Rate Effect retreated to -$1.4 million in Q1 2026, from $418000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $6.2 million in Q3 2024 to a low of -$7.3 million in Q4 2024.
- A 5-year average of $352823.5 and a median of $418000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect soared 1604.17% — and 2024, when it plunged 754.81%.
- Tracing BRNS's Exchange Rate Effect over 5 years: stood at $5.7 million in 2022, then plunged by 80.41% to $1.1 million in 2023, then plunged by 754.81% to -$7.3 million in 2024, then soared by 105.69% to $418000.0 in 2025, then slumped by 423.44% to -$1.4 million in 2026.
- The last three Exchange Rate Effect figures came in at -$1.4 million (Q1 2026), $418000.0 (Q4 2025), and -$1.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 25.29 Mn | 25.29 Mn | - | 471,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 471,000.00 |
| Jun 30, 2026 | 471,000.00 |
| Mar 31, 2026 | -1.35 Mn |
| Mar 31, 2026 | -1.35 Mn |
| Dec 31, 2025 | 418,000.00 |
| Dec 31, 2025 | 418,000.00 |
| Sep 30, 2025 | -1.84 Mn |
| Sep 30, 2025 | -1.84 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | -7.35 Mn |
| Dec 31, 2024 | -7.35 Mn |
| Sep 30, 2024 | 6.18 Mn |
| Sep 30, 2024 | 6.18 Mn |
| Jun 30, 2024 | -357,000.00 |
| Jun 30, 2024 | -357,000.00 |
| Mar 31, 2024 | -492,000.00 |
| Mar 31, 2024 | -492,000.00 |